BG61916B1 - Нови производни на еритромицина и метод за получаването иизползването им като лекарствени средства - Google Patents

Нови производни на еритромицина и метод за получаването иизползването им като лекарствени средства Download PDF

Info

Publication number
BG61916B1
BG61916B1 BG100150A BG10015095A BG61916B1 BG 61916 B1 BG61916 B1 BG 61916B1 BG 100150 A BG100150 A BG 100150A BG 10015095 A BG10015095 A BG 10015095A BG 61916 B1 BG61916 B1 BG 61916B1
Authority
BG
Bulgaria
Prior art keywords
formula
compounds
methyl
radical
compound
Prior art date
Application number
BG100150A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100150A (bg
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BG100150A publication Critical patent/BG100150A/bg
Publication of BG61916B1 publication Critical patent/BG61916B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG100150A 1994-04-08 1995-11-20 Нови производни на еритромицина и метод за получаването иизползването им като лекарствени средства BG61916B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PCT/FR1995/000441 WO1995027720A1 (fr) 1994-04-08 1995-04-06 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
BG100150A BG100150A (bg) 1996-06-28
BG61916B1 true BG61916B1 (bg) 1998-09-30

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100150A BG61916B1 (bg) 1994-04-08 1995-11-20 Нови производни на еритромицина и метод за получаването иизползването им като лекарствени средства

Country Status (49)

Country Link
US (2) US5656607A (cg-RX-API-DMAC7.html)
EP (1) EP0676409B1 (cg-RX-API-DMAC7.html)
JP (1) JP3000023B2 (cg-RX-API-DMAC7.html)
KR (1) KR100317148B1 (cg-RX-API-DMAC7.html)
CN (1) CN1059445C (cg-RX-API-DMAC7.html)
AP (1) AP587A (cg-RX-API-DMAC7.html)
AT (1) ATE234853T1 (cg-RX-API-DMAC7.html)
AU (1) AU684939B2 (cg-RX-API-DMAC7.html)
BG (1) BG61916B1 (cg-RX-API-DMAC7.html)
BR (1) BR9506147A (cg-RX-API-DMAC7.html)
CA (1) CA2164638C (cg-RX-API-DMAC7.html)
CO (1) CO4370097A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296005B6 (cg-RX-API-DMAC7.html)
DE (1) DE69529934T2 (cg-RX-API-DMAC7.html)
DK (1) DK0676409T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ1869A1 (cg-RX-API-DMAC7.html)
EE (1) EE04498B1 (cg-RX-API-DMAC7.html)
ES (1) ES2189820T3 (cg-RX-API-DMAC7.html)
FI (1) FI111264B (cg-RX-API-DMAC7.html)
FR (1) FR2718450B1 (cg-RX-API-DMAC7.html)
GB (1) GB2288174A (cg-RX-API-DMAC7.html)
GE (1) GEP19991836B (cg-RX-API-DMAC7.html)
HR (1) HRP950217B1 (cg-RX-API-DMAC7.html)
HU (1) HU215396B (cg-RX-API-DMAC7.html)
IL (1) IL112954A (cg-RX-API-DMAC7.html)
IS (1) IS1865B (cg-RX-API-DMAC7.html)
JO (1) JO1850B1 (cg-RX-API-DMAC7.html)
LV (1) LV11182B (cg-RX-API-DMAC7.html)
MA (1) MA23501A1 (cg-RX-API-DMAC7.html)
MD (1) MD663G2 (cg-RX-API-DMAC7.html)
MY (1) MY114672A (cg-RX-API-DMAC7.html)
NO (1) NO308361B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ284498A (cg-RX-API-DMAC7.html)
OA (1) OA10200A (cg-RX-API-DMAC7.html)
PE (1) PE2896A1 (cg-RX-API-DMAC7.html)
PL (1) PL180837B1 (cg-RX-API-DMAC7.html)
PT (1) PT676409E (cg-RX-API-DMAC7.html)
RO (1) RO115634B1 (cg-RX-API-DMAC7.html)
RU (1) RU2141965C1 (cg-RX-API-DMAC7.html)
SA (1) SA97170757A (cg-RX-API-DMAC7.html)
SI (1) SI0676409T1 (cg-RX-API-DMAC7.html)
SK (1) SK284079B6 (cg-RX-API-DMAC7.html)
SV (1) SV1995000018A (cg-RX-API-DMAC7.html)
TN (1) TNSN95026A1 (cg-RX-API-DMAC7.html)
TW (1) TW316908B (cg-RX-API-DMAC7.html)
UA (1) UA44705C2 (cg-RX-API-DMAC7.html)
WO (1) WO1995027720A1 (cg-RX-API-DMAC7.html)
YU (1) YU49221B (cg-RX-API-DMAC7.html)
ZA (1) ZA952059B (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
CZ349698A3 (cs) * 1996-05-07 1999-04-14 Abbott Laboratories 3-deskladinoso-2,3-anhydroerythromycinové deriváty
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
DK1291351T3 (da) * 1996-09-04 2005-10-24 Abbott Lab 6-O-substituerede ketolider med antibakteriel aktivitet
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6421398A (en) * 1997-03-24 1998-10-20 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998051696A1 (en) * 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
HUP0002252A3 (en) * 1997-06-11 2002-01-28 Pfizer Prod Inc 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
AU5299499A (en) 1998-09-22 2000-04-10 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
WO2000034297A1 (en) 1998-12-10 2000-06-15 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
IL145777A0 (en) * 1999-04-16 2002-07-25 Kosan Biosciences Inc Macrolide antiinfective agents
CA2370743A1 (en) 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EP1180110A1 (en) * 1999-05-24 2002-02-20 Pfizer Products Inc. 13-methyl-erythromycin derivatives
CA2451391A1 (en) 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
MXPA04012978A (es) 2002-07-01 2005-09-12 Arkion Life Sciences Llc D B A Proceso y material para la produccion de glucosamina y n-acetilglucosamina.
CA2801100A1 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Macrolides and processes for their preparation
WO2004096822A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN102223794B (zh) 2008-10-24 2017-12-22 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
PL2550286T3 (pl) 2010-03-22 2016-07-29 Cempra Pharmaceuticals Inc Krystaliczne postaci makrolidu i ich zastosowanie
CN105198944B (zh) 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN105246334A (zh) 2013-04-04 2016-01-13 哈佛大学的校长及成员们 大环内酯及其制备和使用方法
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
CA2980315A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
FI955913A7 (fi) 1995-12-08
AU684939B2 (en) 1998-01-08
FI955913A0 (fi) 1995-12-08
NO308361B1 (no) 2000-09-04
SA97170757A (ar) 2005-12-03
AP587A (en) 1997-04-29
SK154695A3 (en) 1996-10-02
DZ1869A1 (fr) 2002-02-17
CZ296005B6 (cs) 2005-12-14
EE9500080A (et) 1996-12-16
CA2164638A1 (fr) 1995-10-19
HU215396B (hu) 1998-12-28
PL311871A1 (en) 1996-03-18
CN1126997A (zh) 1996-07-17
GB2288174A (en) 1995-10-11
SV1995000018A (es) 1997-10-24
DK0676409T3 (da) 2003-06-23
IL112954A (en) 2000-07-16
TNSN95026A1 (fr) 1996-02-06
ES2189820T3 (es) 2003-07-16
ZA952059B (en) 1996-03-13
LV11182A (lv) 1996-04-20
KR100317148B1 (ko) 2002-06-22
US5656607A (en) 1997-08-12
FR2718450B1 (fr) 1997-01-10
SI0676409T1 (en) 2003-06-30
PE2896A1 (es) 1996-02-12
BG100150A (bg) 1996-06-28
BR9506147A (pt) 1996-04-16
US5760233A (en) 1998-06-02
GB9506856D0 (en) 1995-05-24
HU9503505D0 (en) 1996-02-28
NO954942L (no) 1996-02-07
YU49221B (sh) 2004-11-25
MD663F1 (ro) 1997-01-31
EE04498B1 (et) 2005-06-15
DE69529934D1 (de) 2003-04-24
DE69529934T2 (de) 2003-09-04
RO115634B1 (ro) 2000-04-28
NO954942D0 (no) 1995-12-06
JPH07278177A (ja) 1995-10-24
CA2164638C (fr) 2003-12-30
SK284079B6 (sk) 2004-09-08
PL180837B1 (pl) 2001-04-30
IL112954A0 (en) 1995-06-29
FI111264B (fi) 2003-06-30
TW316908B (cg-RX-API-DMAC7.html) 1997-10-01
HRP950217A2 (en) 1997-08-31
RU2141965C1 (ru) 1999-11-27
MY114672A (en) 2002-12-31
EP0676409A1 (fr) 1995-10-11
OA10200A (fr) 1996-12-18
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
WO1995027720A1 (fr) 1995-10-19
AP9500743A0 (en) 1995-07-31
PT676409E (pt) 2003-08-29
AU2310795A (en) 1995-10-30
CZ322395A3 (en) 1996-08-14
IS4309A (is) 1995-11-17
GEP19991836B (en) 1999-11-05
LV11182B (en) 1997-04-20
HRP950217B1 (en) 2004-06-30
CO4370097A1 (es) 1996-10-07
MA23501A1 (fr) 1995-12-31
JP3000023B2 (ja) 2000-01-17
CN1059445C (zh) 2000-12-13
YU21695A (sh) 1997-12-05
UA44705C2 (uk) 2002-03-15
FR2718450A1 (fr) 1995-10-13
ATE234853T1 (de) 2003-04-15
HUT73772A (en) 1996-09-30
MD663G2 (ro) 1997-07-31
IS1865B (is) 2003-05-02
NZ284498A (en) 1997-07-27

Similar Documents

Publication Publication Date Title
BG61916B1 (bg) Нови производни на еритромицина и метод за получаването иизползването им като лекарствени средства
CA2189271C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4102440B2 (ja) 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用
US5786339A (en) Erythromycins
KR20010080970A (ko) 에리쓰로마이신의 신규 유도체, 그의 제조 방법 및의약으로서 그의 용도
US6313101B1 (en) Derivatives of erythromycin, their preparation process and their use as medicaments
MXPA99010813A (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamento.
FR2732023A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
AP997A (en) Novel erythromycin derivatives, method for preparing them and their use as medicine.
KR20000068014A (ko) 신규 에리트로마이신 유도체, 그의 제조방법 및 의약으로서의용도
JP2001518475A (ja) 環状亜リン酸およびリン酸塩
KR20000062286A (ko) 신규한 에리트로마이신 유도체, 제조 방법 및 의약품으로서 용도